Management of Junctional Osteoporotic Vertebral Fracture
Initial Conservative Management
- The American Academy of Orthopaedic Surgeons recommends initial conservative management with calcitonin for acute pain relief, combined with bisphosphonates for fracture prevention, for elderly patients with junctional osteoporotic vertebral fracture without neurological symptoms or instability, with vertebral augmentation reserved for patients who fail to achieve adequate pain relief after 3 months of conservative treatment 1, 2
- Calcitonin should be initiated for 4 weeks in patients with acute fractures, as it provides clinically important pain reduction at 1, 2, 3, and 4 weeks 1, 2
- Acetaminophen is recommended as first-line analgesic, particularly in patients with comorbidities such as chronic kidney disease and cardiovascular disease 3
- Evidence for opioids/analgesics is insufficient to make a firm recommendation, though they may be used judiciously in clinical practice 1, 2, 4
Mobilization and Immobilization Strategy
- Avoid prolonged bed rest, as it accelerates bone loss, muscle weakness, and increases risk of deep venous thrombosis 5, 3
- Bracing evidence is inconclusive due to limited studies that did not specify fracture level or age, though it remains a clinical option 1, 4
- Begin early range-of-motion exercises within the first postoperative days to prevent deconditioning 3
Osteoporosis Pharmacotherapy
- Initiate calcium supplementation (1000-1200 mg/day) and vitamin D (800 IU/day) immediately, as these reduce non-vertebral fractures by 15-20% and falls by 20% 6, 3
- Bisphosphonates (alendronate or risedronate) should be started as first-line therapy to prevent subsequent fractures, as they reduce vertebral, non-vertebral, and hip fractures 6, 3
- Ibandronate and strontium ranelate are alternative options for preventing additional symptomatic fractures 1, 2, 4
Monitoring for Treatment Failure
- The VERTOS II trial demonstrated that patients who achieve significant pain relief with conservative management typically do so by 3 months; those without adequate relief by this timepoint are candidates for vertebral augmentation 5
Vertebral Augmentation
- Vertebroplasty or balloon kyphoplasty should be considered for patients with persistent, significant pain after 3 months of conservative treatment 5
- Both vertebroplasty and kyphoplasty are equally effective in substantially reducing pain and disability, with comparable outcomes persisting from 2 to 5 years 5
- Vertebral augmentation has been shown superior to placebo for pain reduction in acute osteoporotic fractures <6 weeks duration, though benefit also extends to subacute and chronic fractures 5
Multidisciplinary Approach
- Orthogeriatric co-management should be implemented immediately in frail elderly patients with multiple comorbidities to improve outcomes 3
- Establish collaboration between orthopedic surgery, rheumatology/endocrinology, and primary care 3
- Surgical consultation is helpful for prescribing and supervising immobilization devices 5
Prevention of Subsequent Fractures
- Implement smoking cessation, limit alcohol intake, and prescribe weight-bearing exercise programs to improve bone mineral density and muscle strength 3
- Implement multidimensional fall prevention programs, which reduce fall frequency by approximately 20% 3
- Address environmental hazards in the home and review medications that may increase fall risk 3
- Bisphosphonates should be continued for 3-5 years, and longer in patients who remain at high risk 6
- For patients with oral intolerance, dementia, malabsorption, or non-compliance, zoledronic acid (intravenous) or denosumab (subcutaneous) are alternatives 6, 3
Common Pitfalls to Avoid
- Do not delay osteoporosis treatment while waiting to see if conservative management succeeds—bisphosphonates should be started immediately regardless of pain management strategy 6, 3
- Avoid high-pulse dosages of vitamin D, as they are associated with increased fall risk 6
Management of Lumbar Compression Fractures in Older Adults with Osteoporosis
1. First‑Line Conservative Management (0–3 months)
- Multimodal analgesia that prioritises acetaminophen over NSAIDs or opioids, combined with early mobilisation and immediate initiation of osteoporosis pharmacotherapy (calcium 1000–1200 mg/day, vitamin D 800 IU/day, and a bisphosphonate such as alendronate or risedronate) is recommended as the initial treatment strategy; vertebral augmentation is reserved for patients with persistent severe pain after three months of conservative care. [7][8]9
2. Analgesic Options
- NSAIDs (e.g., ibuprofen or naproxen) may be used for pain but require caution in older adults because of heightened gastrointestinal, renal, and cardiovascular risks. [8][9]
- Opioids should be prescribed only when absolutely necessary and with extreme caution due to the increased risk of sedation, nausea, deconditioning, and falls in this population. [8][9]
3. Expected Pain Course with Conservative Care
- Most patients experience spontaneous resolution of fracture‑related pain within 6–8 weeks, even without analgesic medication. [8][9]
- Significant pain relief is typically achieved by the three‑month mark for patients who respond to conservative management. [8][9]
4. Definition of Conservative‑Treatment Failure (≈3 months)
- Failure is defined as any of the following: pain that remains refractory to oral analgesics, contraindication to standard analgesics, or the need for parenteral narcotics and hospital admission. [8][9]
5. Evidence for Early Vertebral Augmentation
- Recent randomized evidence demonstrates that vertebral augmentation (vertebroplasty or kyphoplasty) provides superior pain reduction compared with sham/placebo in acute fractures of less than six weeks’ duration, with benefits extending into sub‑acute and chronic phases. [8][9]
6. Indications for Vertebral Augmentation After Failed Conservative Therapy
- Patients with persistent severe pain after three months of optimal conservative treatment should be offered vertebroplasty or balloon kyphoplasty. [7][8]9
7. Comprehensive Fracture‑Risk Assessment (All Patients ≥ 50 years)
- Perform dual‑energy X‑ray absorptiometry (DXA) of the spine and hip to quantify bone mineral density. 10
- Obtain spinal imaging (radiography or vertebral‑fracture assessment) to identify subclinical vertebral fractures. 10
- Systematically review clinical risk factors such as advanced age, female sex, low body‑mass index, personal or family history of fracture, and falls risk. 10
- Screen for secondary causes of osteoporosis (e.g., endocrine disorders, medication‑induced bone loss). 10
- Conduct a formal falls‑risk evaluation, including a history of falls in the preceding year. 10
8. Fracture Liaison Service (FLS) Impact
- Implementation of an FLS with a dedicated coordinator raises the proportion of patients receiving osteoporosis treatment from roughly 26 % to 45 % within six months of fracture identification. 10
9. Urgent Surgical Consultation Criteria
- Immediate surgical referral is indicated for pathologic compression fractures complicated by frank spinal instability or by neurologic deficits; these patients should receive corticosteroids and surgery promptly to prevent further deterioration. 7
10. Timing of Secondary Fracture Risk
- The risk of a subsequent fracture is highest in the period immediately following the index lumbar compression fracture, underscoring the need for rapid osteoporosis treatment and fall‑prevention measures. 10